Related Experiment Video
Updated: Jun 29, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis
Rui-Hong Wang1, Yin Zheng, Hyun-Seok Kim
1Genetics of Development and Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.
Abstract:
Germline mutations of BRCA1 predispose women to breast and ovarian cancers. However, the downstream mediators of BRCA1 function in tumor suppression remain elusive. We found that human BRCA1-associated breast cancers have lower levels of SIRT1 than their normal controls. We further demonstrated that mammary tumors from Brca1 mutant mice have low levels of Sirt1 and high levels of Survivin, which is reversed by induced expression of Brca1. BRCA1 binds to the SIRT1 promoter and increases SIRT1 expression, which in turn inhibits Survivin by changing the epigenetic modification of histone H3. Absence of SIRT1 blocks the regulation of Survivin by BRCA1. Furthermore, we demonstrated that activation of Sirt1 and inhibition of Survivin expression by resveratrol elicit a more profound inhibitory effect on Brca1 mutant cancer cells than on Brca1-wild-type cancer cells both in vitro and in vivo. These findings suggest that resveratrol treatment serves as an excellent strategy for targeted therapy for BRCA1-associated breast cancer.
Insights
BRCA1 mutations increase breast and ovarian cancer risk. This study reveals SIRT1
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Germline mutations in BRCA1 are linked to hereditary breast and ovarian cancers.
- The precise mechanisms of BRCA1 tumor suppression are not fully understood.
- Downstream targets of BRCA1 in cancer prevention require further elucidation.
Purpose of the Study:
- To investigate the role of SIRT1 in BRCA1-associated tumorigenesis.
- To explore the therapeutic potential of targeting SIRT1 and Survivin in BRCA1-mutant cancers.
Main Methods:
- Analysis of SIRT1 and Survivin levels in human BRCA1-associated breast cancers and Brca1 mutant mouse models.
- Investigating BRCA1's interaction with the SIRT1 promoter and its effect on gene expression.
- Assessing the impact of resveratrol on Sirt1 activation and Survivin inhibition in vitro and in vivo.
Main Results:
- BRCA1-associated cancers exhibit reduced SIRT1 and elevated Survivin levels.
- BRCA1 directly upregulates SIRT1 expression, which epigenetically suppresses Survivin.
- Resveratrol demonstrates enhanced efficacy against Brca1 mutant cancer cells by activating Sirt1 and inhibiting Survivin.
Conclusions:
- SIRT1 is a key mediator of BRCA1's tumor suppressor function.
- The SIRT1-Survivin axis is critical in BRCA1-associated cancers.
- Resveratrol represents a promising targeted therapy for BRCA1-associated breast cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

